Pre-Implantation Genetic Screening

NOTICE PAPER NO. 2615
NOTICE OF QUESTION FOR ORAL ANSWER
FOR THE SITTING OF PARLIAMENT ON 29 FEBRUARY 2024 

Name and Constituency of Member of Parliament
Mr Louis Ng Kok Kwang
MP for Nee Soon GRC

Question No. 5786

To ask the Minister for Health whether he can provide an update on (i) the pilot for Pre-Implantation Genetic Screening (PGS) and (ii) when PGS can be included as a mainstream healthcare service.

Answer

1      Under MOH’s pilot on Pre-Implantation Genetic Screening (PGS), any woman enrolled in an accredited in-vitro fertilisation (IVF) programme, who is 35 years and above, who has suffered two or more recurrent implantation failures, or experienced two or more pregnancy losses, is eligible for PGS. This is to improve IVFsuccess rates.  
2      As of January 2024, 590 patients were enrolled to the study but only 195 patients had undergone PGS. Of which, 131 completed their embryo transfers. This has led to 70 pregnancies with 56 live births, and 5 ongoing pregnancies. More patients need to be recruited into the pilot for a robust evaluation of the clinical efficacy of PGS, before it can be determined if PGS can be a mainstream clinical service. In the meantime, PGS will remain accessible to eligible patients.